{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:11:12Z","timestamp":1768893072280,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302582\/2013-4"],"award-info":[{"award-number":["302582\/2013-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005288","name":"Funda\u00e7\u00e3o Amaz\u00f4nia Paraense de Amparo \u00e0 Pesquisa","doi-asserted-by":"publisher","award":["ICAAF 156\/2014"],"award-info":[{"award-number":["ICAAF 156\/2014"]}],"id":[{"id":"10.13039\/501100005288","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universidade Federal do Par\u00e1\/Pr\u00f3-Reitoria de Pesquisa e P\u00f3s-Gradua\u00e7\u00e3o\/Funda\u00e7\u00e3o de Amparo e Desenvolvimento da Pesquisa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cyto.2015.11.004","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T03:46:05Z","timestamp":1446695165000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["IL28B gene polymorphisms and Th1\/Th2 cytokine levels might be associated with HTLV-associated arthropathy"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6950-589X","authenticated-orcid":false,"given":"Keyla Santos Guedes","family":"de S\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Brasil","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuane Carolina","family":"de Souza Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita Catarina Medeiros","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezar Augusto Muniz","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia Nakauth","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosimar Neris Martins","family":"Feitosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Fernando Almeida","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlu\u00edsa","family":"de Oliveira Guimar\u00e3es Ishak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-6507","authenticated-orcid":false,"given":"Antonio Carlos Ros\u00e1rio","family":"Vallinoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.11.004_b0005","unstructured":"Van Regenmortel MHV, Fauquet CM, Bishop DHL, Carstens EB, Estes MK, Lemon SM, et al. Virus Taxonomy. 9th Report of the International Committee on Taxonomy of Viruses. San Diego; 2011."},{"key":"10.1016\/j.cyto.2015.11.004_b0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM198608073150606","article-title":"A second isolate of HTLV-II associated with atypical hairy-cell leukemia","volume":"315","author":"Rosenblatt","year":"1986","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.cyto.2015.11.004_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of Type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-Cell Lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2015.11.004_b0020","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2015.11.004_b0025","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1097\/00042560-199600001-00031","article-title":"Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection","volume":"13","author":"Hall","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.cyto.2015.11.004_b0030","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2015.11.004_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.11.004_b0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S0037-86822002000400015","article-title":"Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy","volume":"35","author":"Ribas","year":"2002","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.cyto.2015.11.004_b0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.1780340612","article-title":"Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features","volume":"34","author":"Sato","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2015.11.004_b0050","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/ard.2010.128736","article-title":"Association of human T lymphotropic virus type I with Sjogren syndrome","volume":"69","author":"Hida","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2015.11.004_b0055","first-page":"252","article-title":"Is there any association between human lymphotropic virus Type I (HTLV-I) infection and systemic lupus erythematosus? An original research and literature review","volume":"16","author":"Shirdel","year":"2013","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.cyto.2015.11.004_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0482-50042005000200005","article-title":"Rheumatic manifestations associated with the human T-cell lymphotropic virus Type I (HTLV-I)","volume":"45","author":"Cruz","year":"2005","journal-title":"Rev. Bras. Reum."},{"key":"10.1016\/j.cyto.2015.11.004_b0065","first-page":"874","article-title":"Synovial hyperplasia in HTLV-I associated arthropathy is induced by tumor necrosis factor-alpha produced by HTLV-I infected CD68+ cells","volume":"27","author":"Yin","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2015.11.004_b0070","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/1529-0131(199811)41:11<1995::AID-ART15>3.0.CO;2-4","article-title":"Extracellular human T cell leukemia virus type 1 TAX protein stimulates the proliferation of human synovial cells","volume":"41","author":"Aono","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2015.11.004_b0075","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/JVI.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type 1","volume":"64","author":"Richardson","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP","volume":"50","author":"Nagai","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cyto.2015.11.004_b0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1745","article-title":"Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells","volume":"14","author":"Jones","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2015.11.004_b0090","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1128\/JVI.71.12.9143-9149.1997","article-title":"Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax : induction of tumor necrosis factor alpha and susceptibility to lysis by CD8 + HTLV-1-specific cytotoxic T Cells","volume":"71","author":"M\u00e9ndez","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I","volume":"12","author":"Bangham","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2015.11.004_b0100","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","article-title":"Cellular immune response to HTLV-1","volume":"24","author":"Bangham","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2015.11.004_b0105","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1126\/science.2843985","article-title":"HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene","volume":"241","author":"Ballard","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.cyto.2015.11.004_b0110","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/13550280390218689","article-title":"Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy\/tropical spastic paraparesis","volume":"9","author":"Barmak","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.cyto.2015.11.004_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2005.04.003","article-title":"Biological activity of interleukins-28 and -29: comparison with type I interferons","volume":"31","author":"Meager","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2015.11.004_b0120","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0125","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0130","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mt.2010.118","article-title":"IL-28B\/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques","volume":"18","author":"Morrow","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cyto.2015.11.004_b0135","first-page":"633","article-title":"Molecular epidemiology of human T-lymphotropic virus type II infection in Amerindian and urban populations of the Amazon region of Brazil","volume":"74","author":"Vallinoto","year":"2002","journal-title":"Hum. Biol. Int. Rec. Res."},{"key":"10.1016\/j.cyto.2015.11.004_b0140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1590\/S0037-86822006000600007","article-title":"HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR","volume":"39","author":"Tameg\u00e3o-lopes","year":"2006","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.cyto.2015.11.004_b0145","doi-asserted-by":"crossref","unstructured":"Barret JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualizations of LD and haplotype maps. 2005.","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"10.1016\/j.cyto.2015.11.004_b0150","unstructured":"M. Ayres, J.R.M. Ayres, D.L. Ayres, A.S. Santos. BioEstat 5.0: Aplica\u00e7\u00f5es estat\u00edsticas nas \u00e1reas das ci\u00eancias biol\u00f3gicas e medicas. 2008."},{"key":"10.1016\/j.cyto.2015.11.004_b0155","unstructured":"GraphPad Software I: Prism (data analysis software system), version 5. Software e Guia do Usu\u00e1rio. 2007."},{"key":"10.1016\/j.cyto.2015.11.004_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4690-2-4","article-title":"Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease","volume":"2","author":"Yakova","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.cyto.2015.11.004_b0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/ard.51.5.673","article-title":"HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid","volume":"51","author":"Eguchi","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2015.11.004_b0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/bbrc.1993.1227","article-title":"Constitutive Expression and producion of tumor necrosis factor-B in T-cell lines infected with HTLV-1 and HTLV-2","volume":"191","author":"Nakajima","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2015.11.004_b0175","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/36.12.1298","article-title":"Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs","volume":"36","author":"Straub","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.cyto.2015.11.004_b0180","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1002\/art.20637","article-title":"Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand","volume":"50","author":"Lee","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2015.11.004_b0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2015.11.004_b0190","first-page":"2049","article-title":"Human T-cell leukemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells","volume":"22","author":"Mori","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2015.11.004_b0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jbspin.2010.03.002","article-title":"Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis","volume":"77","author":"Le Goff","year":"2010","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.cyto.2015.11.004_b0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10428199809068561","article-title":"Interleukin-10 gene expression and adult T-cell leukemia","volume":"29","author":"Mori","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.cyto.2015.11.004_b0205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/intimm\/dxp074","article-title":"Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax","volume":"21","author":"Takatsuka","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2015.11.004_b0210","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","article-title":"Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells","volume":"160","author":"Groux","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.11.004_b0215","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/JVI.74.10.4729-4737.2000","article-title":"Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes","volume":"74","author":"Santin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.actatropica.2012.09.012","article-title":"Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"125","author":"Starling","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.cyto.2015.11.004_b0225","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","article-title":"High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus Type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease","volume":"77","author":"Goon","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2015.11.004_b0230","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/eji.200324610","article-title":"Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells","volume":"34","author":"Coccia","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2015.11.004_b0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/jir.2010.0081","article-title":"The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response","volume":"30","author":"Gallagher","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2015.11.004_b0240","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1182\/blood-2008-11-190520","article-title":"Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity","volume":"113","author":"Morrow","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.11.004_b0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1743-422X-9-40","article-title":"Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus","volume":"9","author":"Kamihira","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.cyto.2015.11.004_b0250","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis343","article-title":"Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms","volume":"55","author":"Trevi\u00f1o","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2015.11.004_b0255","doi-asserted-by":"crossref","first-page":"e3199","DOI":"10.1371\/journal.pntd.0003199","article-title":"IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associatade myelophaty\/Tropical spastic paraparesis (HAM\/TSP) in HTLV-1 carriers","volume":"8","author":"Assone","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.cyto.2015.11.004_b0260","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2010.09.019","article-title":"IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy","volume":"54","author":"Abe","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2015.11.004_b0265","doi-asserted-by":"crossref","first-page":"e19799","DOI":"10.1371\/journal.pone.0019799","article-title":"Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C","volume":"6","author":"Onomoto","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2015.11.004_b0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00535-010-0287-4","article-title":"IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice","volume":"45","author":"Ahlenstiel","year":"2010","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cyto.2015.11.004_b0275","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00262-012-1203-y","article-title":"Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma","volume":"61","author":"Ren","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cyto.2015.11.004_b0280","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2011.050351","article-title":"IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection","volume":"97","author":"Di Marco","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2015.11.004_b0285","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1073\/pnas.1100349108","article-title":"Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy","volume":"108","author":"Hsu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2015.11.004_b0290","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4254\/wjh.v5.i11.635","article-title":"IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase","volume":"5","author":"Miyamura","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cyto.2015.11.004_b0295","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4049\/jimmunol.155.3.1588","article-title":"Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans","volume":"155","author":"Iwakura","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.11.004_b0300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2015.11.004_b0305","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar1997","article-title":"Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies","volume":"8","author":"Proost","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2015.11.004_b0310","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.25647","article-title":"Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response","volume":"56","author":"Naggie","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.11.004_b0315","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jac\/dkr598","article-title":"Impact of IL28B gene polymorphisms on interferon-\u03bb3 plasma levels during pegylated interferon-\u03b1\/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV","volume":"67","author":"Rall\u00f3n","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cyto.2015.11.004_b0320","doi-asserted-by":"crossref","first-page":"e30607","DOI":"10.1371\/journal.pone.0030607","article-title":"Genetic variations in IL28B and allergic disease in children","volume":"7","author":"Gaudieri","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2015.11.004_b0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2015.11.004_b0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2015.11.004_b0335","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1471-2334-12-374","article-title":"Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load","volume":"12","author":"Sanabani","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2015.11.004_b0340","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.3748\/wjg.v19.i42.7399","article-title":"Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?","volume":"19","author":"Garcia","year":"2013","journal-title":"World J. Gastroenterol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T07:02:18Z","timestamp":1718175738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615300922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":68,"alternative-id":["S1043466615300922"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.11.004","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL28B gene polymorphisms and Th1\/Th2 cytokine levels might be associated with HTLV-associated arthropathy","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}